Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 4, 2014, Pages 2052-2058

  Tarning, Joel ^a,b   Lindegardh, Niklas ^a,b   Lwin, Khin Maung ^a   Annerberg, Anna ^a,b   Kiricharoen, Lily ^a   Ashley, Elizabeth ^a,b   White, Nicholas J ^a,b   Nosten, François ^a,b   Day, Nicholas P J ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROARTEMISININ PLUS PIPERAQUINE; PIPERAQUINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG FORMULATION; EFFECT SIZE; FOOD; FOOD DRUG INTERACTION; FOOD INTAKE; HUMAN; LOW FAT DIET; MALARIA FALCIPARUM; MIDDLE AGED; MONTE CARLO METHOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIMALARIALS; FASTING; HUMANS; MALARIA, FALCIPARUM; MIDDLE AGED; MONTE CARLO METHOD; QUINOLINES; YOUNG ADULT;

EID: 84896981219     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02318-13     Document Type: Article

References (29)

1. WHO. 2012. World malaria report 2012. World Health Organization, Geneva, Switzerland.
2. Zwang J, Ashley EA, Karema C, D'Alessandro U, Smithuis F, Dorsey G, Janssens B, Mayxay M, Newton P, Singhasivanon P, Stepniewska K, White NJ, Nosten F. 2009. Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis. PLoS One 4:e6358. http://dx.doi.org/10.1371/journal.pone.0006358.
3. WHO. 2010. Guidelines for the treatment of malaria, 2nd ed. World Health Organization, Geneva, Switzerland.
4. Tarning J, Zongo I, Some FA, Rouamba N, Parikh S, Rosenthal PJ, Hanpithakpong W, Jongrak N, Day NP, White NJ, Nosten F, Ouedraogo JB, Lindegardh N. 2012. Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria. Clin. Pharmacol. Ther. 91:497-505. http://dx.doi.org/10.1038/clpt.2011.254.
5. Tarning J, Ashley EA, Lindegardh N, Stepniewska K, Phaiphun L, Day NP, McGready R, Ashton M, Nosten F, White NJ. 2008. Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin- piperaquine in patients with Plasmodium falciparum malaria in Thailand. Antimicrob. Agents Chemother. 52:1052-1061. http://dx.doi.org/10.1128/AAC.00955- 07. (Pubitemid 351358388)
6. Tarning J, Lindegardh N, Annerberg A, Singtoroj T, Day NP, Ashton M, White NJ. 2005. Pitfalls in estimating piperaquine elimination. Antimicrob. Agents Chemother. 49:5127-5128. http://dx.doi.org/10.1128/AAC.49.12.5127-5128. 2005. (Pubitemid 41778931)
7. Tarning J, Rijken MJ, McGready R, Phyo AP, Hanpithakpong W, Day NP, White NJ, Nosten F, Lindegardh N. 2012. Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria. Antimicrob. Agents Chemother. 56:1997-2007. http://dx.doi.org/10.1128/AAC.05756-11.
8. Tarning J, Lindegardh N, Sandberg S, Day NJ, White NJ, Ashton M. 2008. Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat. J. Pharm. Sci. 97:3400-3410. http://dx.doi.org/10.1002/jps.21226.
9. Ashley EA, Stepniewska K, Lindegardh N, Annerberg A, Kham A, Brockman A, Singhasivanon P, White NJ, Nosten F. 2007. How much fat is necessary to optimize lumefantrine oral bioavailability? Trop. Med. Int. Health 12:195-200. http://dx.doi.org/10.1111/j.1365-3156.2006.01784.x.
10. Milton KA, Edwards G, Ward SA, Orme ML, Breckenridge AM. 1989. Pharmacokinetics of halofantrine in man: effects of food and dose size. Br. J. Clin. Pharmacol. 28:71-77. http://dx.doi.org/10.1111/j.1365-2125.1989.tb03507.x. (Pubitemid 19195667)
11. Crevoisier C, Handschin J, Barre J, Roumenov D, Kleinbloesem C. 1997. Food increases the bioavailability of mefloquine. Eur. J. Clin. Pharmacol. 53:135-139. http://dx.doi.org/10.1007/s002280050351. (Pubitemid 27491666)
12. Rolan PE, Mercer AJ, Weatherley BC, Holdich T, Meire H, Peck RW, Ridout G, Posner J. 1994. Examination of some factors responsible for a food-induced increase in absorption of atovaquone. Br. J. Clin. Pharmacol. 37:13-20. http://dx.doi.org/10.1111/j.1365-2125.1994.tb04232.x. (Pubitemid 24204575)
13. Sim IK, Davis TM, Ilett KF. 2005. Effects of a high-fat meal on the relative oral bioavailability of piperaquine. Antimicrob. Agents Chemother. 49:2407-2411. http://dx.doi.org/10.1128/AAC.49.6.2407-2411.2005. (Pubitemid 40734473)
14. Nguyen TC, Nguyen NQ, Nguyen XT, Bui D, Travers T, Edstein MD. 2008. Pharmacokinetics of the antimalarial drug piperaquine in healthy Vietnamese subjects. Am. J. Trop. Med. Hyg. 79:620-623. http://www.ajtmh.org/content/79/4/ 620.long.
15. Hai TN, Hietala SF, Van Huong N, Ashton M. 2008. The influence of food on the pharmacokinetics of piperaquine in healthy Vietnamese volunteers. Acta Trop. 107:145-149. http://dx.doi.org/10.1016/j.actatropica.2008.05.013.
16. Annerberg A, Lwin KM, Lindegardh N, Khrutsawadchai S, Ashley E, Day NP, Singhasivanon P, Tarning J, White NJ, Nosten F. 2011. A small amount of fat does not affect piperaquine exposure in patients with malaria. Antimicrob. Agents Chemother. 55:3971-3976. http://dx.doi.org/10.1128/AAC.00279-11.
17. Lindegardh N, Annerberg A, White NJ, Day NP. 2008. Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 862:227-236. http://dx.doi.org/10.1016/j.jchromb.2007.12.011.
18. Lindbom L, Pihlgren P, Jonsson EN. 2005. PsN-Toolkit - a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput. Methods Programs Biomed. 79:241-257. http://dx.doi.org/10. 1016/j.cmpb.2005.04.005. (Pubitemid 41196689)
19. Lindbom L, Ribbing J, Jonsson EN. 2004. Perl-speaks-NONMEM (PsN) - a Perl module for NONMEM related programming. Comput. Methods Programs Biomed. 75:85-94. http://dx.doi.org/10.1016/j.cmpb.2003.11.003. (Pubitemid 38798039)
20. Jonsson EN, Karlsson MO. 1999. Xpose - an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comput. Methods Programs Biomed. 58:51-64. (Pubitemid 29049052)
21. Keizer RJ, van Benten M, Beijnen JH, Schellens JH, Huitema AD. 2011. Pirana and PCluster: a modeling environment and cluster infrastructure for NONMEM. Comput. Methods Programs Biomed. 101:72-79. http://dx.doi.org/10.1016/j. cmpb.2010.04.018.
22. Savic RM, Jonker DM, Kerbusch T, Karlsson MO. 2007. Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies. J. Pharmacokinet. Pharmacodyn. 34:711-726. http://dx.doi.org/10.1007/ s10928-007-9066-0. (Pubitemid 47477040)
23. Ravva P, Gastonguay MR, Tensfeldt TG, Faessel HM. 2009. Population pharmacokinetic analysis of varenicline in adult smokers. Br. J. Clin. Pharmacol. 68:669-681. http://dx.doi.org/10.1111/j.1365-2125.2009.03520.x.
24. Vong C, Bergstrand M, Nyberg J, Karlsson MO. 2012. Rapid sample size calculations for a defined likelihood ratio test-based power in mixed-effects models. AAPS J. 14:176-186. http://dx.doi.org/10.1208/s12248-012-9327-8.
25. Beal SL. 2001. Ways to fit a PK model with some data below the quantification limit. J. Pharmacokinet. Pharmacodyn. 28:481-504. http://dx.doi.org/10.1023/A:1012299115260. (Pubitemid 33151426)
26. Hoglund RM, Adam I, Hanpithakpong W, Ashton M, Lindegardh N, Day NP, White NJ, Nosten F, Tarning J. 2012. A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan. Malar. J. 11:398. http://dx.doi.org/10.1186/1475- 2875-11-398.
27. Price R, Simpson JA, Teja-Isavatharm P, Than MM, Luxemburger C, Heppner DG, Chongsuphajaisiddhi T, Nosten F, White NJ. 1999. Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria. Antimicrob. Agents Chemother. 43:341-346. (Pubitemid 29079169)
28. Zhu Y, Hsu WH, Hollis JH. 2013. The impact of food viscosity on eating rate, subjective appetite, glycemic response and gastric emptying rate. PLoS One 8:e67482. http://dx.doi.org/10.1371/journal.pone.0067482.
29. Lwin KM, Phyo AP, Tarning J, Hanpithakpong W, Ashley EA, Lee SJ, Cheah P, Singhasivanon P, White NJ, Lindegardh N, Nosten F. 2012. Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria. Antimicrob. Agents Chemother. 56:1571-1577. http://dx.doi.org/10.1128/ AAC.05877-11.